Search Results - Andrew Intlekofer
- Showing 1 - 2 results of 2
-
1
Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphoma by Rabeya Molla, Kurt Bantilan, Ellin Berman, Philip Caron, Lorenzo Falchi, Paul Hamlin, Steven Horwitz, Andrew Intlekofer, Anita Kumar, Jennifer Lue, Alison Moskowitz, Colette Owens, Maria Lia Palomba, Parastoo Bahrami Dahi, Gilles Salles, Santosha Vardhana, Gunjan Shah, Andrew Zelenetz, William Johnson, Ariela Noy
Published in Haematologica (2025-08-01)Get full text
Article -
2
T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory... by Alison J. Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Samia Sohail, Alayna Santarosa, Charisse Capadona, Brittney Munayirji, Anita Kumar, Oscar Lahoud, Connie Batlevi, Paul Hamlin, David J. Straus, Colette Owens, Philip Caron, Andrew Intlekofer, Audrey Hamilton, Steven Horwitz, Lorenzo Falchi, William Johnson, Lia Palomba, Ariela Noy, Matthew Matasar, Georgios Pongas, Gilles Salles, Santosha Vardhana, Beatriz Wills Sanin, Joachim Yahalom, Ahmet Dogan, Andrew Zelenetz, Craig H. Moskowitz
Published in HemaSphere (2022-10-01)Get full text
Article
